HIV-exposed seronegative individuals (HESIs) are a small fraction of persons who are
multiply exposed to human immunodeficiency virus (HIV), but do not exhibit serological or …

Research has undergone considerable development in understanding a small subset of
human immunodeficiency virus type 1 (HIV-1)-infected, therapy-naive individuals who …

With 133 million individuals infected with human immunodeficiency virus type 1 (HIV-1)
worldwide, and with 12 million more individuals infected every year [1], the need for an …

Summary Less than 0.5% of human immunodeficiency virus‐1 (HIV‐1)‐infected patients
maintain viral load below the threshold of detection by conventional assays for many years …

ABSTRACT HIV-1 elite controllers (EC) maintain undetectable viral loads (VL) in the
absence of antiretroviral treatment. However, these subjects have heterogeneous clinical …

HIV disease is a culmination of a complex interplay between both viral and host factors. As
the underlying biological and molecular mechanisms involved in determining disease status …

Despite the varying disease progression rates, the majority of HIV-infected individuals
eventually progress to AIDS. There is a subset of HIV-positive individuals, who maintain high …

Two HIV virus types exist: HIV-1 is pandemic and aggressive, whereas HIV-2 is confined
mainly to West Africa and less pathogenic. Despite the fact that it has been almost 40 years …

Untreated HIV-1 infection typically progresses to AIDS within 10 years, but less than 1% of
infected individuals remain healthy and have normal CD4+ T cell counts and undetectable …

The mechanisms by which a small percentage of HIV-1 infected individuals known as elite
suppressors or controllers are able to control viral replication are not fully understood. Early …